Insights

AI in Healthcare Medial EarlySign offers machine learning based decision support tools that provide personalized risk assessments and predictive insights from standard medical data, presenting a clear opportunity to sell advanced AI-driven clinical decision support to hospitals, health systems, and research institutions seeking proactive patient management.

Clinical Validation The company is conducting clinical trials across 14 leading research institutions involving over 5 million patients, signaling strong validation potential for payer and provider partnerships looking for evidence-backed solutions and scalable deployment in real-world settings.

Partnership Momentum Historical partnerships with Roche, Geisinger, and Otros demonstrate a proven pathway for co-development and commercialization of AI diagnostic tools, suggesting strategic alliances as a viable route to expand market access and accelerate adoption.

Disease Focus Product lines such as LungFlag and influenza-focused Algomarker initiatives indicate a specialization in high-burden conditions with strong market pull, offering targeted upsell opportunities to hospital systems prioritizing respiratory and infectious disease risk management.

Growth Readiness With revenue in the low millions and a lean headcount, Medial EarlySign appears poised for scalable partnerships and channel strategies that can convert enterprise-level pilots into broader deployments within mid to large healthcare organizations.

Similar companies to Medial EarlySign

Medial EarlySign Tech Stack

Medial EarlySign uses 8 technology products and services including Google AdSense, Hotjar, Amazon Web Services, and more. Explore Medial EarlySign's tech stack below.

Media & News

Medial EarlySign's Email Address Formats

Medial EarlySign uses at least 4 email formats:
Medial EarlySign Email FormatsExamplePercentage
First@earlysign.comJohn@earlysign.com
56%
FirstL@earlysign.comJohnD@earlysign.com
29%
First.Last@earlysign.comJohn.Doe@earlysign.com
9%
FiLast@earlysign.comJoDoe@earlysign.com
6%

Frequently Asked Questions

What is Medial EarlySign's official website and social media links?

Minus sign iconPlus sign icon
Medial EarlySign's official website is earlysign.com and has social profiles on LinkedIn.

How much revenue does Medial EarlySign generate?

Minus sign iconPlus sign icon
As of October 2026, Medial EarlySign's annual revenue is estimated to be $1M - $10M.

What is Medial EarlySign's NAICS code?

Minus sign iconPlus sign icon
Medial EarlySign's NAICS code is 62 - Health Care and Social Assistance.

How many employees does Medial EarlySign have currently?

Minus sign iconPlus sign icon
As of October 2026, Medial EarlySign has approximately 8 employees across 2 continents, including Asia and Africa. Key team members include Coo, Cfo , Chief Commercial Officer Eu: I. K., Vp Product: R. G. and Director Of Information Technology: G. S. Explore Medial EarlySign's employee directory with LeadIQ.

What industry does Medial EarlySign belong to?

Minus sign iconPlus sign icon
Medial EarlySign operates in the Hospitals and Health Care industry.

What technology does Medial EarlySign use?

Minus sign iconPlus sign icon
Medial EarlySign's tech stack includes Google AdSense, Hotjar, Amazon Web Services, WordPress, CookieYes, Microsoft 365, Google Analytics and Download Monitor.

What is Medial EarlySign's email format?

Minus sign iconPlus sign icon
Medial EarlySign's email format typically follows the pattern of First@earlysign.com. Find more Medial EarlySign email formats with LeadIQ.

When was Medial EarlySign founded?

Minus sign iconPlus sign icon
Medial EarlySign was founded in 2013.
Medial EarlySign logo

Medial EarlySign

Hospitals and Health CareCentral District, Israel2-10 Employees

Medial EarlySign develops machine learning-based decision-support tools that reveal hidden information in standard medical data. These insights enable personalized predictions and treatment options and support early identification of life-threatening conditions. The platform processes large volumes of medical data and generates thousands of parameters to analyze trends and interrelationships over time, enabling population-level risk stratification and flagging individuals who may require intervention. The company emphasizes clinical validation through trials conducted at 14 leading research institutions worldwide, involving more than 5 million patients.

Based in Hod Hasharon, Central District, Israel, the organization serves healthcare providers seeking proactive, personalized, and predictive care management. A notable recent development is the November 2023 launch of LungFlag.

Section iconCompany Overview

NAICS Code
62 - Health Care and Social Assistance
Founded
2013
Employees
2-10

Section iconFunding & Financials

  • $1M - $10M

    Medial EarlySign's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.